SCHEMBL20174530

SCHEMBL20174530

c1cncc(-c2nc(-c3cccnc3)nc(-c3ccc4c(c3)-c3ccccc3C43c4ccccc4-c4sc5ccccc5c43)n2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
MAPT P10636 3/20 0.38
RAB9A P51151 2/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PDK2 Q15119 2/20 0.36
ABCG2 Q9UNQ0 7/20 0.36
CYP11B1 P15538 1/20 0.36
CYP1A2 P05177 4/20 0.35
CYP3A4 P08684 4/20 0.35
CLK4 Q9HAZ1 3/20 0.35
TSHR P16473 3/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
GBA1 P04062 1/20 0.35
NPC1 O15118 1/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174511 0.98 ALDH1A1 (0.39) ALDH1A1MAPTRAB9AKDM4EHPGD
SCHEMBL20174480 0.86 MEN1 (0.33) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL20174436 0.84 ALOX5 (0.34) ALDH1A1MAPTKDM4EHPGDLMNA
SCHEMBL20174654 0.84 PDK2 (0.39) ALDH1A1MAPTRAB9AKDM4EHPGD
SCHEMBL20174455 0.83 KDM4E (0.34) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL22326533 0.83 MEN1 (0.34) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL20174445 0.83 MEN1 (0.34) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL20174521 0.83 S1PR1 (0.35) ALDH1A1MAPTRAB9AKDM4EHPGD
SCHEMBL18590025 0.82 PDK2 (0.42) ALDH1A1MAPTRAB9AKDM4EHPGD
SCHEMBL20174513 0.82 PDK2 (0.38) ALDH1A1MAPTRAB9AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG ALDH1A1 33/4885MAPT 811/4885RAB9A 2250/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG ALDH1A1 33/4885MAPT 811/4885RAB9A 2250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.